Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Cancer|January 3, 2001
Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomyS R Potter, L A Mangold, M J Shue, et al.
Urology|October 1, 1996
Histopathologic characterization of hereditary benign prostatic hyperplasiaC B Doehring, M G Sanda, A W Partin, et al.
Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.
The Journal of Urology|June 1, 1997
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, G J Gormley, et al.
Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.
European Urology|January 1, 1990
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapyW B Isaacs, J T Isaacs, N Kyprianou, et al.
Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.
Urology|January 14, 1999
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancerC F Eisenberger, P C Walsh, M A Eisenberger, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Cancer|January 3, 2001
Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomyS R Potter, L A Mangold, M J Shue, et al.
Urology|October 1, 1996
Histopathologic characterization of hereditary benign prostatic hyperplasiaC B Doehring, M G Sanda, A W Partin, et al.
Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.
The Journal of Urology|June 1, 1997
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, G J Gormley, et al.
Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.
European Urology|January 1, 1990
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapyW B Isaacs, J T Isaacs, N Kyprianou, et al.
Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.
Urology|January 14, 1999
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancerC F Eisenberger, P C Walsh, M A Eisenberger, et al.
Pageof 24